Fresenius opens €200m gateway fund for emerging biotech talent
CompaniesFresenius
Signals
Every pharma-relevant, de-duplicated event surfaced so far, primary source first. Client-scoped signals are never shown here.
New schema resolves subject ID challenges in CRO sector, researchers say
mAb combo therapy misses the mark in Phase III clinical trial for advanced colorectal cancer
CompaniesBristol Myers SquibbMirati TherapeuticsAssetscetuximabadagrasibDiseasesadvanced colorectal cancer
Partnership-first approach: Inside Servier's Asia innovation strategy
CompaniesServierBioNovaInsilico Medicine
Eyes on Asia: Tanabe Pharma, KYAN Technologies, Biogen
CompaniesAxiomPathos AISamsung Biologics
Getting siRNAs into the brain without transferrin receptors
CompaniesManifold BioAssetsantibodiesoligosDiseasesamyotrophic lateral sclerosis (ALS)Alzheimer's
Xencor’s Celia Eckert explains why psychological safety is the foundation of a compliant culture
CompaniesXencor
SK pharmteco Marks Construction Progress with Ribbon Cutting for Two Advanced Manufacturing Facilities at Swords, Ireland Campus
CompaniesSK pharmteco
Applied Biologics Announces Acceptance of XWRAP® Translational Research for Presentation at SAWC Fall 2026
CompaniesApplied BiologicsAssetsXWRAP
Co-Diagnostics Participates in Medical Devices and Innovations Roundtable Media Event
CompaniesCo-Diagnostics
Kenai Therapeutics Appoints Mark Gergen to Board of Directors
CompaniesKenai Therapeutics
GE HealthCare appoints William Grogan as Chief Financial Officer
CompaniesGE HealthCare
Cytovance Biologics Launches Standalone Analytical Services to Accelerate Biologics Development
CompaniesCytovance Biologics
Aqua Medical Treats First West Coast Patient in FDA-Approved IDE Trial of Investigational PIMA Procedure for Type 2 Diabetes
CompaniesAqua MedicalAssetsPIMA procedureradiofrequency vapor ablation (RFVA) platformDiseasestype 2 diabetes
TempraMed Executes Definitive Exclusive Distribution Agreement with TEM in Panama, Advancing Commercial Expansion Across Clinics and Pharmacies
CompaniesTempraMed Technologies Ltd.TEM Consulting International S.A.
PharmaTher Selects PD Labs, a National 503A Compounding Pharmacy, as the U.S. Center of Excellence for Its Personalized Medicine and Peptide Platform, PERSONALIZ3D(TM)
CompaniesPharmaTherPD Labs
AstraZeneca partners with CSPC to build Chinese biologics manufacturing plant
CompaniesAstraZenecaCSPC Pharmaceutical
Jazz commits up to $1.3B to buy Actio, bolster epilepsy pipeline
CompaniesJazz PharmaceuticalsActio Biosciences
After billions in deals, Insilico CEO promises: ‘You haven't seen anything yet’
CompaniesInsilico MedicineEli LillyTakedaExelixisBoehringer IngelheimSK Biopharmaceuticals
Sentynl bets up to $475M in licensing deal for Mereo’s rare lung disease asset
CompaniesMereo BioPharmaSentynl TherapeuticsZydus LifesciencesAssetsalvelestatDiseasesalpha-1 antitrypsin deficiency-associated lung disease (AATD-LD)